Navigation Links
Varian Medical Systems to Introduce Two New PaxScan(R) Flat-Panel Digital Radiography Products at RSNA This Year
Date:11/21/2007

PALO ALTO, Calif., Nov. 21 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR), a premier supplier of X-ray tubes and the PaxScan(R) line of digital X-ray image detectors, will introduce two new PaxScan products at the annual meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from November 25 - 30, 2007.

-- The PaxScan 4336R adds a 14 x 17 inch detector to Varian's broad line

of flat panel products. It is specifically designed to replace a

standard film cassette for use in radiographic applications.

-- The PaxScan 4343R is Varian's largest flat-panel X-ray image detector.

At 17 x 17 inches, it is designed for permanent mounting in

radiographic tables or wall stands, or for any application that

requires a large field of view.

Except for their physical size, both panels incorporate identical detector arrays and readout electronics, making them excellent radiographic imaging solutions for any general purpose room. Image data and control signals, which are based upon an industry standard Gigabit Ethernet interface, can be passed to and from these detectors using standard network interface cards. Images are transmitted instantaneously to the image processor for display and diagnosis. Housings and cable attachments are designed for simple integration into any diagnostic imaging system.

Both of these panels come bundled with VIVA(TM) software, a system design and development application for image acquisition and viewing on a workstation running Microsoft(R) Windows(TM). This software package provides an easy way for the original equipment manufacturer or system integrator to begin image analysis and system design quickly. Also included with VIVA is a complete Dynamic Link Library (DLL) to facilitate simple software development. Sample code is provided to ease the design of detector set-up and calibration, image acquisition, and image optimization. All Varian X-ray products come with excellent applications support to help customers with system design and development.

In addition to these new products, Varian will exhibit the company's full line of X-ray tubes, as well as the company's cancer treatment technologies, including the market-leading Eclipse(TM) radiotherapy treatment planning system for planning and adapting conformal radiation therapy treatments on the basis of 3-D image data.

High resolution images of these and other Varian products are available in the company's online newsroom at: http://varian.mediaroom.com/index.php?s=media_library.

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,500 people who are located at manufacturing sites in North America and Europe and approximately 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

FOR INFORMATION CONTACT:

Meryl Ginsberg, (650) 424-6444

meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... , ... June 20, 2017 , ... Uniform Advantage ... collection featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA ... and cotton easy care stretch twill. , With trendy looks hitting the medical community, ...
(Date:6/20/2017)... ... June 20, 2017 , ... John D'Eri, CEO of ... Leader in Adult Autism Award during the Autism Society of America 's ... The Daniel Jordan Fiddle Foundation (DJFF) was founded in 2002 as the ...
(Date:6/20/2017)... ... 20, 2017 , ... International water advocate Sharon Kleyne is ... Power of Water, Global Climate Change and Your Health on VoiceAmerica sponsored by ... how it affects the human eyes. , According to Sharon Kleyne and ...
(Date:6/20/2017)... Chevy Chase, MD (PRWEB) , ... June 20, 2017 , ... ... across the nation, the Society of Professional Benefit Administrators (SPBA) has provided input to ... letter with Sens. Mitch McConnell (R - KY), Charles E. Schumer (D - ...
(Date:6/19/2017)... ... June 19, 2017 , ... Intrinsic Clinical ... the international exchange of actionable insights to improve health globally through the advancement ... make clinical trial management faster, easier, and less painful. Attendees can visit Intrinsic’s ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... 50 years ago today, the Monterey Pop Festival opened its ... San Francisco "Summer of Love."  To celebrate the anniversary, Northern ... strategic market research portals that it will begin delivering to ... Light,s "Summer of Love (For Our Customers)."  ... Northern ...
(Date:6/14/2017)... -- In 2016, Embodied Labs took top prize ... came away with $25,000 in seed-fund investment. Embodied Labs ... "entering the life of another" and by the Journal ... medical professionals in an entirely new dimension." Building upon ... for the Department of Education,s EdSimChallenge, where they received ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: